Connection

Jean Nappi to Humans

Back to Details
This is a "connection" page, showing publications Jean Nappi has written about Humans.
Jean Nappi
Connection Strength
0.261
Humans
  1. An academician preparation program for pharmacy residents. Am J Pharm Educ. 2013 Jun 12; 77(5):101.
    View in: PubMed
    Score: 0.017
  2. Assessment of prescribers' knowledge of the cost of medications. Ann Pharmacother. 2012 Feb; 46(2):200-7.
    View in: PubMed
    Score: 0.015
  3. Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure. Vasc Health Risk Manag. 2011; 7:353-63.
    View in: PubMed
    Score: 0.014
  4. Barriers to clopidogrel adherence following placement of drug-eluting stents. Ann Pharmacother. 2009 Feb; 43(2):259-67.
    View in: PubMed
    Score: 0.012
  5. Benefits and limitations of current antiplatelet therapies. Am J Health Syst Pharm. 2008 Jul 01; 65(13 Suppl 5):S5-10; quiz S16-8.
    View in: PubMed
    Score: 0.012
  6. What is a pharmacotherapy residency? Benefits of a 24-month program. Pharmacotherapy. 2008 Jul; 28(7):819-20.
    View in: PubMed
    Score: 0.012
  7. Prevalence of anemia in clinic patients with heart failure and cost analysis of epoetin treatment. Pharmacotherapy. 2007 May; 27(5):707-14.
    View in: PubMed
    Score: 0.011
  8. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. Pharmacotherapy. 2006 Apr; 26(4):461-8.
    View in: PubMed
    Score: 0.010
  9. The role of B-type natriuretic peptide in heart failure. Crit Care Nurs Clin North Am. 2003 Dec; 15(4):461-5.
    View in: PubMed
    Score: 0.009
  10. The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonist. Clin Ther. 2003 Nov; 25(11):2647-68.
    View in: PubMed
    Score: 0.009
  11. Anemia in patients with coronary artery disease. Am J Health Syst Pharm. 2003 Jul 15; 60(14 Suppl 3):S4-8.
    View in: PubMed
    Score: 0.008
  12. Bosentan for the treatment of pulmonary arterial hypertension. Ann Pharmacother. 2003 Jul-Aug; 37(7-8):1055-62.
    View in: PubMed
    Score: 0.008
  13. Role of race in the pharmacotherapy of heart failure. Ann Pharmacother. 2002 Mar; 36(3):471-8.
    View in: PubMed
    Score: 0.008
  14. Advice Provided by a Pharmacy Residency Research Committee. Ann Pharmacother. 2021 12; 55(12):1547-1549.
    View in: PubMed
    Score: 0.007
  15. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann Pharmacother. 2001 May; 35(5):589-617.
    View in: PubMed
    Score: 0.007
  16. Clinical use of new antithrombotic therapies for medical management of acute coronary syndromes. Pharmacotherapy. 2001 Mar; 21(3):320-37.
    View in: PubMed
    Score: 0.007
  17. Myocardial infarction in women: a critical appraisal of gender differences in outcomes. Pharmacotherapy. 2000 Sep; 20(9):1034-44.
    View in: PubMed
    Score: 0.007
  18. Vitamins for the management of cardiovascular disease: a simple solution to a complex problem? Pharmacotherapy. 1999 Dec; 19(12):1400-14.
    View in: PubMed
    Score: 0.007
  19. The association of the combination of sumatriptan and methysergide in myocardial infarction in a premenopausal woman. Arch Intern Med. 1999 Mar 08; 159(5):511-3.
    View in: PubMed
    Score: 0.006
  20. Key Articles and Guidelines in the Management of Heart Failure: 2018 Update. J Pharm Pract. 2019 Feb; 32(1):77-92.
    View in: PubMed
    Score: 0.006
  21. Adjunctive intracoronary thrombolysis in complicated coronary angioplasty. Ann Pharmacother. 1997 Oct; 31(10):1244-6.
    View in: PubMed
    Score: 0.006
  22. Pharmacy residency training measured through a standardized knowledge test. Am J Health Syst Pharm. 2016 Dec 15; 73(24):2095-2098.
    View in: PubMed
    Score: 0.005
  23. Possible pharmacokinetic interaction with quinidine: ciprofloxacin or metronidazole? Ann Pharmacother. 1996 Apr; 30(4):364-6.
    View in: PubMed
    Score: 0.005
  24. Vorapaxar in atherosclerotic disease management. Ann Pharmacother. 2015 May; 49(5):599-606.
    View in: PubMed
    Score: 0.005
  25. Sotalol: a breakthrough antiarrhythmic? Ann Pharmacother. 1993 Nov; 27(11):1359-68.
    View in: PubMed
    Score: 0.004
  26. Concomitant amiodarone and the implantable cardioverter-defibrillator: is there a place? Ann Pharmacother. 1993 Jun; 27(6):736-41.
    View in: PubMed
    Score: 0.004
  27. Multi-institutional study of women and underrepresented minority faculty members in academic pharmacy. Am J Pharm Educ. 2012 Feb 10; 76(1):7.
    View in: PubMed
    Score: 0.004
  28. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother. 2011 Dec; 55(12):5475-9.
    View in: PubMed
    Score: 0.004
  29. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. J Card Fail. 2010 Mar; 16(3):188-93.
    View in: PubMed
    Score: 0.003
  30. Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis. Ann Pharmacother. 2008 Jun; 42(6):904-5.
    View in: PubMed
    Score: 0.003
  31. Type 2 diabetes mellitus and heart failure. Pharmacotherapy. 2008 Feb; 28(2):170-92.
    View in: PubMed
    Score: 0.003
  32. Comments on draft of work force document. Am J Health Syst Pharm. 2006 Sep 01; 63(17):1592.
    View in: PubMed
    Score: 0.003
  33. Professional practice plans: recommendations from the 2005 Council of Faculties-Council of Deans Task Force. Am J Pharm Educ. 2006 Jun 15; 70(3):S03.
    View in: PubMed
    Score: 0.003
  34. Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmias. Eur J Clin Pharmacol. 1986; 31(1):15-22.
    View in: PubMed
    Score: 0.002
  35. Assessment of compliance with lipid guidelines in an academic medical center. Ann Pharmacother. 2006 Jan; 40(1):27-31.
    View in: PubMed
    Score: 0.002
  36. Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance study. Am J Cardiol. 1984 Feb 01; 53(4):522-7.
    View in: PubMed
    Score: 0.002
  37. Glycoprotein IIb/IIIa receptor inhibitors in percutaneous coronary intervention and acute coronary syndrome. Ann Pharmacother. 2003 Jun; 37(6):860-75.
    View in: PubMed
    Score: 0.002
  38. Efficacy of intravenous pirmenol hydrochloride for treatment of ventricular arrhythmias: a controlled comparison with lidocaine. J Cardiovasc Pharmacol. 1983 Mar-Apr; 5(2):213-20.
    View in: PubMed
    Score: 0.002
  39. Combination antiplatelet therapy: implications for pharmacists. J Am Pharm Assoc (Wash). 2002 Nov-Dec; 42(6):880-3.
    View in: PubMed
    Score: 0.002
  40. Clinical efficacy of amiodarone. Pharmacotherapy. 1998 Nov-Dec; 18(6 Pt 2):127S-137S.
    View in: PubMed
    Score: 0.002
  41. Antihypertensive monotherapy with tablet (prompt-release) diltiazem: multicenter controlled trials. Cardiovasc Drugs Ther. 1990 Aug; 4(4):1089-96.
    View in: PubMed
    Score: 0.001
  42. Sustained-release diltiazem: duration of antihypertensive effect. J Clin Pharmacol. 1989 Jun; 29(6):533-7.
    View in: PubMed
    Score: 0.001
  43. Metabolic effects of antihypertensive therapy with a calcium antagonist. Am J Cardiol. 1988 Oct 05; 62(11):109G-113G.
    View in: PubMed
    Score: 0.001
  44. The disposition of recainam hydrochloride during and after intravenous loading and maintenance infusion in cardiac patients. J Clin Pharmacol. 1987 Dec; 27(12):951-6.
    View in: PubMed
    Score: 0.001
  45. Flecainide: a new prototype antiarrhythmic agent. Pharmacotherapy. 1985 Jul-Aug; 5(4):209-21.
    View in: PubMed
    Score: 0.001
  46. Individualization of phenytoin dosage regimens. Clin Pharmacol Ther. 1977 Mar; 21(3):287-93.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.